TAIZHOU, China, April 14, 2022 — Jiangsu Recbio Technology Co Ltd (Stock code:2179.HK) says the company has received approval from the Ministry of Health and Prevention of the United Arab Emirates to conduct a Phase II/III clinical study of sequential booster vaccination for its recombinant protein ReCOV.
The